chrisvoncsefalvay/vaers-outcomes huggingface dataset:
no adverse event; A 15-year-old patient was administered M-M-R II; A 15-year-old patient was administered Proquad; This spontaneous report was received from a nurse concerning a 15-year-old male patient. No information was provided regarding the patient's pertinent medical history, concomitant medications or drug reactions/allergies. On 29-JUN-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (dosage schedule, anatomical location, route of administration, lot number and expiration date were not reported). On 29-JUL-2019, the patient received measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), lot number R030797 and expiration date 22-APR-2020 (dosage schedule, anatomical location and route of administration were not reported) (product administered to patient of inappropriate age). On 30-AUG-2019, the patient received measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) for prophylaxis (dosage schedule, anatomical location, route of administration, lot number and expiration date were not reported) (product administered to patient of inappropriate age).
8 days after vaccine the injection site is swollen and warm to touch. Shoulder, neck sore
High fever up to 103.9, extended high fever for multiple days. Chest tightness, shortness of breath, elevated heart rate when at rest. Body aches and headache, chills.By the second day it?s mostly just tightness and shortness of breath and some chest pain.
pt recvd vax 5OCT95 & 7OCT95 devel pink papular vesicular rash around inj site lt thigh 15cm radius on neck & hands;
Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Weakness-Medium, Additional Details: After 15 minutes had passed after vaccination, the immunizer went to give the patient his vaccination card and it was then that he told her he didnt feel well. RPH went to assit the patient who complained of dizziness and needing air. Pt appeared weak and disoriented. Patients eyes were almost closed. RPH called 911 patient was very disoriented but refused treatment by emts and went home with parents
Violent chills for 2 hours, sweats for 12 hours, prostration for 24 hours, muscle weakness and pain continuing at 72 hour point.  200 mg. Ibuprofen every 6 hours gave significant relief of muscle pain.  Still very weak.
weakness; like when you're really hungry and your stomach growls a little bit, that's what's happening in their chest; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness) and CHEST PAIN (like when you're really hungry and your stomach growls a little bit, that's what's happening in their chest) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included LISINOPRIL for Hypertension.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced CHEST PAIN (like when you're really hungry and your stomach growls a little bit, that's what's happening in their chest). On an unknown date, the patient experienced ASTHENIA (weakness). At the time of the report, ASTHENIA (weakness) and CHEST PAIN (like when you're really hungry and your stomach growls a little bit, that's what's happening in their chest) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information as not reported.
after getting the vaccine at 3 pm the feet turned red and tender. there was some swelling by the next morning. this is still a symptom going on since the shot
I immediately had pain at the injection site. I started having a cough within the first 10 minutes. After 30 minutes, I experienced nausea and a slight headache. The headache worsened and became unbearable after two hours. I needed to fill a bag with ice and massage my entire head. I felt I was going to hemorrhage. My nausea worsened, and I vomited and had stomach pains and had to run to the toilet to evacuate my bowels. I was shaking from the pain. I needed to go to the hospital but am without insurance.  I cannot afford another hospital bill. I dealt with the pain throughout the first night and found that the headache had decreased in intensity by day two. I continued to have pain in my arm for around 4 days after my first dose.  I have my second dose scheduled for 4/20/21 at Pharmacy and am concerned since I am not certain what I can expect.
Pt. experienced numbness & tingling at site of inj, local redness, and feeling of paresthesia continues to have months afterwards. Also had same reaction with previous injection.
Itchy mainly in head ears slight swelling around my eyes.  My throat ticked  I had a headache and felt tired    It feels like it is starting to get better today so far
Janssen-Covid 19- EUA 41 yo Female who recieved single dose of Janseen lot # 180890 at approx 910 this morning.  During observation pt had no complaint of any symptoms. Pt returned to work shortly after, pt started to feel itchy on her arms, neck and back.  pt also stated more red bumps on face.  Pt states possible reaction to shrimp last month but was unaware if it was or not. Pt denied any sob,diff breathing, pt did have rash on arms and shoulders. Fire was activated. pt signed ama with Fire Department.
This is a spontaneous report from a contactable other healthcare professional via a Pfizer sales representative. A female patient of an unspecified age started to receive PREVNAR 13, via an unspecified route of administration on an unspecified date at single dose for immunization. Medical history included respiratory syncytial virus (RSV) infection at around 12 months old. The patient's concomitant medications were not reported. The reporter had a friend that had twin daughters that are 13. One of the twins had RSV at around 12 months old. She had the recommended pneumococcal vaccines as a baby per the Centers for Disease Control recommendations. She had pneumonia yearly at time of the report for several years. The outcome of the event was unknown. Sender's Comments: Based on the information currently available, a lack of efficacy with pneumococcal 13-valent conjugate vaccine in this patient cannot be completely excluded. Further information like confirmative pathological/serotype results are needed for full medical assessment.
adverse event; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of ADVERSE EVENT (adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (adverse event). At the time of the report, ADVERSE EVENT (adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment drugs were reported
Late period - abnormal for patient, unknown pregnancy status at time of vaccination. Started bleeding 5 days after expected start date. Unsure if this is related to vaccination at all but patient has been very regular every other cycle and that is the only change this month so wanted to report in case their are any other similar reports.
3-5 pox marks on body;afeb;began 11MAR98-still has on 13MAR98;
After 4 mo vaccine, baby had ? fever with seizures which were under control. After 6 mol; she again had febrile sz after vaccinated and went to ER.
Headache, Myalgia, Fever, Fatigue, Injection site pain. Narrative:
swollen; red circle; Tiny little bumps; warm to the touch; Chills; Horrific migraine; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MIGRAINE (Horrific migraine), PERIPHERAL SWELLING (swollen), ERYTHEMA (red circle) and MASS (Tiny little bumps) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 02SL20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Atrial fibrillation and Arthritis.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 26-Feb-2021, the patient experienced MIGRAINE (Horrific migraine) and CHILLS (Chills). On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen), ERYTHEMA (red circle), MASS (Tiny little bumps) and VACCINATION SITE WARMTH (warm to the touch). On 26-Feb-2021, MIGRAINE (Horrific migraine) had resolved. On 27-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (swollen), ERYTHEMA (red circle), MASS (Tiny little bumps) and VACCINATION SITE WARMTH (warm to the touch) outcome was unknown.            Treatment included none concomitants -high blood pressure medicine, blood thinner   This case was linked to MOD-2021-030483 (Patient Link).
Weak/ feeling weak; Bones are hurting all over the body; Hot to touch injection site (left arm); Swelling at injection site (left arm); Tender injection site (left arm); Very tired; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak/ feeling weak), BONE PAIN (Bones are hurting all over the body), VACCINATION SITE WARMTH (Hot to touch injection site (left arm)), VACCINATION SITE SWELLING (Swelling at injection site (left arm)) and VACCINATION SITE PAIN (Tender injection site (left arm)) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939901 and 034C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Sep-2021, the patient experienced ASTHENIA (Weak/ feeling weak), BONE PAIN (Bones are hurting all over the body), VACCINATION SITE WARMTH (Hot to touch injection site (left arm)), VACCINATION SITE SWELLING (Swelling at injection site (left arm)), VACCINATION SITE PAIN (Tender injection site (left arm)) and FATIGUE (Very tired). At the time of the report, ASTHENIA (Weak/ feeling weak), BONE PAIN (Bones are hurting all over the body), VACCINATION SITE WARMTH (Hot to touch injection site (left arm)), VACCINATION SITE SWELLING (Swelling at injection site (left arm)), VACCINATION SITE PAIN (Tender injection site (left arm)) and FATIGUE (Very tired) outcome was unknown.            Concomitant product was not provided by the reporter. Treatment information was not provided.
This spontaneous report as received from a pharmacist via a company representative refers to a female patient of unknown age. No concurrent information or medical history was provided. On 07-OCT-2014, the patient was vaccinated with a dose of PNEUMOVAX23 injection (lot # J013345 with expiry date: 11-JAN-2015; strength, dose, route of administration and indication  unspecified in the arm. No concomitant medications were reported. The pharmacist (who also administered the vaccine) reported that ht patient experienced swelling from injection site down to their elbow. In October 2014 (exact date unknown), after being administered PNEUMOVAX23). The pharmacist participated in a Flu Clinic. No treatment was given. The outcome of swelling was reported as recovering. The relatedness between the event and PNEUMOVAX23 was not reported. Additional information has been requested.
Patient received Pfizer Covid-19 pediatric dose when she she have received the  Pfizer Covid-19 adult dose. Patient is 12 years old.
booster; sore arm; Mild headache; mild body aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose), for Covid-19 Immunization; Bnt162b2 (2nd dose), for Covid-19 Immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "booster"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm"; HEADACHE (non-serious), outcome "unknown", described as "Mild headache"; PAIN (non-serious) with onset 2021, outcome "unknown", described as "mild body aches".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Booster; Swollen painful left armpit; Swollen painful left armpit; hard / red / painful lump at vaccine site about the size of a silver dollar; hard / red / painful lump at vaccine site about the size of a silver dollar; hard / red / painful lump at vaccine site about the size of a silver dollar; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received third dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: FF2590) via an unspecified route of administration, administered in left arm on 25Oct2021 13:30 (at the age of 34-year-old) as dose 3 (booster), single for covid-19 immunisation at Pharmacy or Drug Store. The patient was not pregnant at the time of vaccination. The patient medical history was not reported. Concomitant medication in two weeks included drospirenone (SLYND) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EN6205) on 04Mar2021 and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: ER8730) on 01Apr2021, both administered in left arm for covid-19 immunisation at Pharmacy or Drug Store. Patient received first dose of Flu vaccine in left arm on 04Oct2021. On 25Oct2021, the patient experienced swollen painful left armpit, hard / red / painful lump at vaccine site about the size of a silver dollar. Patient did not had covid prior vaccination and was not tested for covid post vaccination. No treatment was received for events. Outcome of events was not recovered at the time of reporting.  Follow-up attempts are completed. No further information is expected.
Very severe dizziness that woke me from sleep, severe nausea, diarrhea, minor headache, cold sweats (but no fever), sore arm (pain behind the shoulder and at the injection site.)  This lasted for two days, followed by fatigue and nausea for another day, with occasional dizziness for a continued week.
Patient picked up cephalexin today. Patient reports taking cephalexin for a skin and soft tissue infection in her arm where her immunizations were administered.
localized reaction involving erythema and mild induration directly from injection site (approximately 3 inches) Patient complained of significant tenderness at site that increased following the injection for approximately 2-3 days
pt devel redness, swelling & tenderness to touch on lt thigh p/4hrs of vax;t100.4 R @ 430PM;
ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA 6/17/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Information has been received from a consumer concerning her daughter, an 18 year old with a history of tonsillectomy, and heavy periods which cause anaemia. On 07-DEC-2007, the patient was vaccinated with her first dose of Gardasil. On 08-DEC-2007 the patient experienced fine rash on legs. On 08-Feb-2008, the patient received her second dose of Gardasil. Concomitant therapy included ZYRTEC-D and hormonal contraceptives (unspecified). On 09-FEB-2008 the patient experienced fine rash on legs. The patient's fine rash on legs persisted. The patient sought unspecified medical treatment and unspecified lab diagnostics were performed. The report states the therapy was discontinued on 08-Feb-2008. Additional information has been requested. On 14-FEB-2008 the patient was diagnosed with eczema on her legs and stomach. Follow up information indicated the patient recovered on an unknown date. Additional information has been requested.
ADMINISTRATION OF VACCINE FROM AFFECTED VIALS DUE TO TEMPERATURE EXCURSION; INCORRECT PRODUCT STORAGE; This spontaneous report received from a pharmacist concerned a 64 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808986, expiry: 02-OCT-2021) dose was not reported, administered on 21-JUN-2021 for prophylactic vaccination. No concomitant medications were reported.  On 21-JUN-2021, the patient experienced administration of vaccine from affected vials due to temperature excursion. On 21-JUN-2021, the patient experienced incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration of vaccine from affected vials due to temperature excursion and incorrect product storage was not reported. This report was non-serious. This case, from the same reporter is linked to 20210915719, 20210915661, 20210916715, 20210917163, 20210916907, 20210916553, 20210916768, 20210913164, 20210915623, 20210916520, 20210915646, 20210915731, 20210915748, 20210915852, 20210916129, 20210916228, 20210916300, 20210916312, 20210916401, 20210916415, 20210916455, 20210916465, 20210916498, 20210916584, 20210916658, 20210916697, 20210916808, 20210916811, 20210916849, 20210916910, 20210916959, 20210916965, 20210917074, 20210917160, 20210917226, 20210917500 and 20210917603.
At noon on 2/25/03 had itchy moles that progressed to red dots on forearms and legs with itching. Seen at ER at 20:00 (approx.) and dx'd with mild clinical vaccinia. Treated with medications and to return to clinic as necessary.
No additional AE reported; administered PROQUAD concomitantly with VARIVAX; This spontaneous report was received from an medical assistant and referring to a 13-month-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported.  On 28-NOV-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin (rHA)) (PROQUAD) subcutaneous injection, lot #W012739, expiration date: 16-OCT-2023, concomitantly with  varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U002399, expiration date: 22-JAN-2023, administered for prophylaxis (both strength, dose and route of administration were not provided) (overdose). No additional adverse event (AE) reported (no adverse event).
elevated white cell count of 11800, blood cell count of 15000, now down to 13000/ Moderna vaccine could cause Leukocytosis and a elevated unintelligible; This spontaneous case was reported by a physician and describes the occurrence of LEUKOCYTOSIS (elevated white cell count of 11800, blood cell count of 15000, now down to 13000/ Moderna vaccine could cause Leukocytosis and a elevated unintelligible) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In October 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LEUKOCYTOSIS (elevated white cell count of 11800, blood cell count of 15000, now down to 13000/ Moderna vaccine could cause Leukocytosis and a elevated unintelligible). At the time of the report, LEUKOCYTOSIS (elevated white cell count of 11800, blood cell count of 15000, now down to 13000/ Moderna vaccine could cause Leukocytosis and a elevated unintelligible) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2021, White blood cell count: 11800 (High) elevated white cell count of 11800. In January 2022, White blood cell count: 15000 (High) blood cell count of 15000. In February 2022, White blood cell count: 13000 (High) down to 13000.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications details and treatment details were not reported by the reporter.   Reportedly, Patient had no allergies to medications, food and other products and there was no acute and Chronic illnesses at the time of vaccination.  Patient never experienced similar events in the past and have no symptoms that could have improved or worsened, neither seek any medical care (office visit, Urgent care, ER, hospitalized). Patient who was a physician asked that the Moderna vaccine could cause Leukocytosis or not and a elevated white blood cell count  was unintelligible, and very suspicious which can be vaccinated induce but he could not be absolute sure also patient did not have any other medications that could cause this event, therefore had an appointment with a Hematologist.  Patient height was reported as 7 Foot 1 Inch.   This case was linked to MOD-2022-488673 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Feb-2022: Follow-up document contains updated patient demographics and route of administration of suspect vaccine.
She got her vaccine, she had numbness and pinch from the vaccine, feels the same as the flu vaccine.  She has a lump under her axilla on the left arm underneath the arm, armpit of her left arm.  She took an aspirin the first day, but has not taken anything else.  She has not notified her doctor.  It is getting larger from the first day but is not warm to touch.   She did have the whooping cough vaccine in May on the same arm, and did not have any reaction from that.
Red bumpy rash with extreme itching and slight swelling for 2 days until I dosed with Benedryl.  After dosing every 4 hours for 2 days, it subsided.   Will call my doctor today!
Hives on R back leg. A few on stomach and L leg. Saw dermatologist on 11-2-09 and was diagnosed with severe reaction to H1N1 vaccine.
Patient first called to report on November 22, 2019 at 1400  Patient details state had an adverse reaction to vaccine. Patient reports she has be to a Chiropractor, Physical Therapy and 2 Doctors since the vaccine. We have been trying to contact the patient since November 22, 2019, but has not returned out phone calls, submitting report in a timely manner after phone call with VAERS, with incomplete data to have record
On 12-18-2021. Exactly one  week after my Janssen Booster shot I woke up with redness and swollen face, knees and shoulders, and back of my neck. I don't know if you would call it hives or a rash or covid arm. It is not at the site of injection in my left arm.